🔬 Science 5h ago

View Channel →

0 0 Save Read Full Article Source ↗ 👁 0 💬 0

Researchers at the Center for Regenerative Medicine (CReM) at Boston Medical Center (BMC) and Boston University (BU) have developed a scalable method for generating CD4+ helper T cells from induced pluripotent stem cells (iPSCs), overcoming a longstanding challenge in the development of stem cell-based immunotherapies. The findings, published in Stem Cell Reports, could help advance efforts to create off-the-shelf CAR-T cell therapies that can be produced at scale and made more readily available

Sign in to join the discussion

NYC’s Most Famous Nightclub Announces Stance On Smart Glasses: Even Try To Bring Them In, You’re Banned Forever

Futurism · 4h ago

Short, intense storms gain intensity across Hawaiʻi

Phys.org - latest science and technology news stories · 4h ago

Shear flow in narrow channels sparks amyloid formation, experiments reveal

Phys.org - latest science and technology news stories · 4h ago

Parkinson's disease imposes growing economic burden on Europe, analysis finds

Medical Xpress - latest medical and health news stories · 4h ago

Scientists Analyzed Earth's Hidden Seed Vaults And Made a Disturbing Realization

ScienceAlert · 4h ago

📰

Perfect pitch was long thought to require a rare predisposition and musical training in early childhood. But a University of Surrey study published in February 2025 found that adults could develop it: after eight weeks of intensive training, two of 12 musicians identified all 12 notes with speed and accuracy comparable to people with naturally acquired perfect pitch.

ScienceBlog.com · 4h ago